<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1803245061
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2024
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Famotidine Amarox
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        FAMOTIDINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="M/s Annora Pharma Private Limited" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            M/s Annora Pharma Private Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2950]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Saudi Amarox
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Saudi Amarox
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BA03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Famotidine belongs to a group of medicines called H2&minus;receptor antagonists. These work by reducing<br />the amount of acid you produce in your stomach.<br />Famotidine is used to treat the following:<br />&bull;Stomach ulcers (gastric/duodenal ulcers)<br />&bull;Mild to moderate irritation and inflammation caused by stomach acid leaking up into the gullet<br />(reflux oesophagitis)<br />&bull;Zollinger&minus;Ellison Syndrome (a rare disorder that involves recurrent ulcers and tumours in the<br />stomach and intestines)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Famotidine if:</strong></p><p>You are allergic to Famotidine, other H2&minus;receptor antagonists or any of the other ingredients of this medicine (listed in section 6)</p><p>&nbsp;</p><p>Warnings and precautions</p><p><strong>Talk to your doctor before taking Famotidine if:</strong></p><p>&bull;&nbsp; There is a possibility of a malignant growth (tumour) being present in your stomach</p><p>&bull;&nbsp; You suffer from kidney problems</p><p>&bull;&nbsp; You have been taking a high dose of Famotidine for a long time. Your doctor may monitor your blood count and liver function</p><p>Other medicines and Famotidine</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those obtained without prescription. This includes herbal medicines.</p><p>Medicines which <strong>may interact </strong>with Famotidine</p><p>&bull;&nbsp; Ketoconazole (should be administered 2 hours before Famotidine) or Itraconazole, used to treat fungal infections</p><p>&bull;&nbsp; Probenicid, used to treat gout</p><p>&bull;&nbsp; Antacids, for indigestion (famotidine should be administered 1-2 hours before taking an antacid)</p><p>&bull;&nbsp; Sucralfate, used to treat and prevent the recurrence of ulcers (sucralfate should not be administered within 2 hours of taking famotidine)</p><p>&bull;&nbsp; Calcium carbonate, when used as a medicine for high blood phosphate levels in patients on dialysis</p><p>&bull;&nbsp; Atazanavir, used for treatment of HIV infection</p><p>Pregnancy and breast&minus;feeding</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.</p><p>Pregnant</p><p>If you are pregnant or suspect you are pregnant, you <strong>should not take </strong>Famotidine unless your doctor thinks the benefits outweigh the risks.</p><p>Breast-feeding</p><p>If you are breast&minus;feeding, you should either <strong>stop taking </strong>Famotidine or <strong>stop breast-feeding </strong>as it is excreted in breast milk.</p><p>Driving and using machines</p><p>Whilst taking Famotidine you may feel dizzy or have a headache. If you develop these symptoms, you should not drive or operate machinery or do activities which require you to be alert and have quick reactions.</p><p>&nbsp;</p><p>Famotidine contains lactose</p><p>Famotidine contains lactose monohydrate. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Always take Famotidine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</strong></p><p>&bull;&nbsp; These tablets are to be taken orally.</p><p>&bull;&nbsp; The score line is only there to help you break the tablet if you have difficulty swallowing it whole.</p><p>&bull;&nbsp; Famotidine can be taken with or without food.</p><p>Adults and Elderly Stomach Ulcers</p><p>&bull;&nbsp; The recommended dose is 40mg once a day at night.</p><p>&bull;&nbsp; The duration of treatment will normally be between 4&minus;8 weeks. In most cases the ulcer will heal with this treatment within 4 weeks. If your ulcer has not healed completely, treatment may be continued for another 4 weeks.</p><p>&bull;&nbsp; For treatment of a recurrent ulcer, the recommended dose is 20mg at night.</p><p>Zollinger&minus;Ellison Syndrome</p><p>The recommended dose is 20mg every six hours. The dosage should then be adjusted.</p><p>Reflux Oesophagitis</p><p>&bull;&nbsp; The recommended dose for treating mild symptoms is 20mg twice a day.</p><p>&bull;&nbsp; The recommended dose for treating mild to moderate symptoms is 40mg twice a day.</p><p>&bull;&nbsp; Treatment should be continued for 6&minus;12 weeks.</p><p>Patients with Kidney disorders/on dialysis</p><p>&bull;&nbsp; If you suffer from kidney disorders, your doctor is likely to reduce your dose.</p><p>&bull;&nbsp; Famotidine should be administered at the end of dialysis or after since some of the active ingredient is removed by dialysis.</p><p>Use in children</p><p>Famotidine are <strong>not </strong>recommended for children.</p><p>If you take more Famotidine than you should</p><p>If you accidentally take too many tablets, contact your doctor or nearest hospital emergency department</p><p><strong>immediately </strong>for advice. Remember to take this leaflet or any remaining tablets with you.</p><p>&nbsp;</p><p>If you forget to take your Famotidine</p><p>Take it as soon as you remember, unless it is nearly time for your next dose. If you miss a dose, do <strong>not</strong></p><p>take a double dose to make up for a forgotten dose.</p><p>If you stop taking Famotidine</p><p>It is important that you keep taking Famotidine for as long as your doctor has told you to.</p><p>In case of long-standing ulcer disease, abrupt withdrawal after symptom relief should be avoided. If you have any further questions on the use of this medicine, ask your doctor or pharmacist</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Famotidine can cause side effects, although not everybody gets them.</p><p>Seek medical advice immediately if you develop the following symptoms:</p><p>&bull;&nbsp; Allergic reactions: swelling of the face throat or tongue, difficulty in breathing or dizziness (anaphylaxis)</p><p>&bull;&nbsp; Difficulty in breathing or wheezing (bronchospasm)</p><p>&bull;&nbsp; Severe blistering of the skin, mouth, eyes and genitals (Stevens Johnson syndrome, toxic epidermal necrolysis)</p><p>&bull;&nbsp; Shortness of breath or dry cough due to inflammation of the lungs (interstitial pneumonia)</p><p>&bull;&nbsp; Swelling of the deeper layers of the skin caused by a build-up of fluid (angioneurotic oedema)</p><p><strong>Common side effects </strong>(may affect up to 1 in 10 people)</p><p>&bull;&nbsp; Headache</p><p>&bull;&nbsp; Dizziness</p><p>&bull;&nbsp; Constipation</p><p>&bull;&nbsp; Diarrhoea</p><p><strong>Uncommon side effects </strong>(may affect up to 1 in 100 people)</p><p>&bull;&nbsp; Feeling and/or being sick (nausea/vomiting)</p><p>&bull;&nbsp; Abdominal pain</p><p>&bull;&nbsp; Excessive wind/feeling bloated (flatulence)</p><p>&bull;&nbsp; Tiredness (fatigue)</p><p>&bull;&nbsp; Dry mouth</p><p>&bull;&nbsp; Loss of appetite (anorexia)</p><p>&bull;&nbsp; Taste disorder</p><p>&bull;&nbsp; Severe itching (pruritus)</p><p>&bull;&nbsp; Rash</p><p>&bull;&nbsp; Skin rashes with the formation of wheals (urticaria)</p><p>&nbsp;</p><p><strong>Rare side effects </strong>(may affect up to 1 in 1,000 people)</p><p>&bull;&nbsp; An increase in liver enzymes in the blood (detected through blood tests)</p><p><strong>Very rare side effects </strong>(may affect less than 1 in 10,000 people)</p><p>&bull;&nbsp; Reduction in blood platelets, which increases risk of bleeding or bruising (thrombocytopenia)</p><p>&bull;&nbsp; Reduction in white blood cells (leukopenia, neutropenia),</p><p>&bull;&nbsp; Reduction in white blood cells which may make infections more likely (agranulocytosis)</p><p>&bull;&nbsp; Reduction in blood cells which can cause weakness, bruising or make infections more likely (pancytopenia)</p><p>&bull;&nbsp; Reversible psychic disturbances including:</p><p>o&nbsp; Hallucinations (seeing or hearing things that are not real)</p><p>o&nbsp; Disorientation</p><p>o&nbsp; Confusion</p><p>o&nbsp; Anxiety disorders</p><p>o&nbsp; Restlessness (agitation)</p><p>o&nbsp; Depression</p><p>o&nbsp; Disorders of sexual function (reduced libido)</p><p>o&nbsp; Difficulty in sleeping (insomnia)</p><p>&bull;&nbsp; Inability to maintain an erection (impotence)</p><p>&bull;&nbsp; Tingling or numbness in the hands or feet (paraesthesia)</p><p>&bull;&nbsp; Sleepiness or drowsiness (somnolence)</p><p>&bull;&nbsp; Fits (convulsions), epileptic seizures including grand mal seizures (particularly in patients with kidney problems)</p><p>&bull;&nbsp; Hair loss (alopecia)</p><p>&bull;&nbsp; Chest tightness</p><p>&bull;&nbsp; Muscle cramps</p><p>&bull;&nbsp; Joint pain (arthralgia)</p><p>&bull;&nbsp; Inflammation of liver (hepatitis)</p><p>&bull;&nbsp; Yellowing of the skin and whites of the eyes (jaundice)</p><p>&bull;&nbsp; Abnormal liver function tests</p><p>&bull;&nbsp; Worsening of existing liver disease</p><p>&bull;&nbsp; Abnormal heart rhythm where the heart beats too slowly (AV block)</p><p>&bull;&nbsp; Disrupted heart rhythm/irregular heartbeat (arrhythmias)</p><p>&bull;&nbsp; Heart rhythm condition that may cause a fast heartbeat (QT prolongation) (especially in patients with impaired kidney function)</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Other side effects</p><p>&bull;&nbsp; Enlargement of breasts in men (gynaecomastia) (not known if caused by Famotidine)</p><p>&nbsp;</p><p>Reporting of side effects</p><p><strong>&nbsp;</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&bull;&nbsp; Saudi Arabia<em>:</em></p><p><strong><em>&nbsp;</em></strong></p><p><!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
  <v:stroke joinstyle="miter"/>
  <v:path gradientshapeok="t" o:connecttype="rect"/>
 </v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t202" style='position:absolute;
  margin-left:58.45pt;margin-top:9.55pt;width:409.45pt;height:114pt;z-index:-15727104;
  mso-wrap-distance-left:0;mso-wrap-distance-right:0;
  mso-position-horizontal-relative:page' filled="f" strokeweight=".48pt">
  <v:textbox inset="0,0,0,0">
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoBodyText style='margin-top:0in;margin-right:88.75pt;
     margin-bottom:0in;margin-left:13.3pt;margin-bottom:.0001pt;text-indent:
     -3.0pt;line-height:187%'>The National Pharmacovigilance and Drug Safety
     Centre (NPC)<span style='letter-spacing:-2.85pt'> </span>o<span
     style='letter-spacing:-.05pt'> </span>SFDA<span style='letter-spacing:
     -.05pt'> </span>Call Center: 19999<o:p></o:p></p>
     <p class=MsoBodyText style='margin-left:19.3pt;text-indent:-9.2pt;
     mso-list:l1 level1 lfo1;tab-stops:19.35pt'><![if !supportLists]><span
     style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
     </span></span><![endif]><span dir=LTR></span><a
     href="mailto:npc.drug@sfda.gov.sa"><span style='color:windowtext;
     text-decoration:none;text-underline:none'>E-mail:npc.drug@sfda.gov.sa</span></a><o:p></o:p></p>
     <p class=MsoBodyText style='margin-top:.25pt'><span style='font-size:11.5pt;
     mso-bidi-font-size:12.0pt'><o:p>&nbsp;</o:p></span></p>
     <p class=MsoBodyText style='margin-left:19.3pt;text-indent:-9.2pt;
     mso-list:l1 level1 lfo1;tab-stops:19.35pt'><![if !supportLists]><span
     style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
     </span></span><![endif]><span dir=LTR></span>Website:https://ade.sfda.gov.sa/<o:p></o:p></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
  <w:wrap type="topAndBottom" anchorx="page"/>
 </v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><img width="552" height="158" alt="Text Box: The National Pharmacovigilance and Drug Safety Centre (NPC) o SFDA Call Center: 19999
o	E-mail:npc.drug@sfda.gov.sa

o	Website:https://ade.sfda.gov.sa/
" src="file:///C:/Users/Pc/AppData/Local/Temp/msohtmlclip1/01/clip_image001.gif" /></td></tr></tbody></table><p><!--[if gte vml 1]></o:wrapblock><![endif]--></p><p>&nbsp;</p><p><strong>o Other GCC States:</strong></p><p>Please contact the relevant competent authority</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date, which is stated on the carton, bottle and blister after EXP. The expiry date refers to the last day of that month.</p><p>This medicinal product does not require any special storage conditions.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>1.&nbsp;&nbsp;&nbsp; What Peploc contains</p><p>The active substance is Famotidine</p><p>&nbsp;</p><p>Peploc (Famotidine Tablets USP 10mg)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each tablet contains 10 mg of Famotidine USP.</p><p>&nbsp;</p><p><strong>The other ingredients are: </strong>Microcrystalline Cellulose (Avicel-PH101), Corn Starch (Extra white maize Strach), Sodium Starch Glycolate Type A (Primojel), Hypromellose 2910 5cps (Methocel E5-LV Premium), Microcrystalline Cellulose (Avicel-PH102) and Magnesium stearate (Ligamed MF-2-V).</p><p><strong>Film coating composition: </strong>Hypromellose 2910, Hydroxyl Propyl Cellulose, Titanium dioxide, Talc and Carnuba Wax<strong>.</strong></p><p>Peploc (Famotidine Tablets USP 20mg)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each tablet contains 20 mg of Famotidine USP.</p><p>&nbsp;</p><p><strong>The other ingredients are: </strong>Microcrystalline Cellulose (Avicel-PH101), Corn Starch (Extra white maize Strach), Sodium Starch Glycolate Type A (Primojel), Hypromellose 2910 5cps (Methocel E5-LV Premium), Microcrystalline Cellulose (Avicel-PH102) and Magnesium stearate (Ligamed MF-2-V).</p><p><strong>Film coating composition: </strong>Hypromellose 2910, Hydroxyl Propyl Cellulose, Titanium dioxide, Talc, Carnuba Wax<strong>, </strong>Yellow Iron Oxide and Red Iron Oxide.</p><p>Peploc (Famotidine Tablets USP 40mg)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Each tablet contains 40 mg of Famotidine USP</p><p>&nbsp;</p><p><strong>The other ingredients are: </strong>Microcrystalline Cellulose (Avicel-PH101), Corn Starch (Extra white maize Strach), Sodium Starch Glycolate Type A (Primojel), Hypromellose 2910 5cps (Methocel E5-LV Premium), Microcrystalline Cellulose (Avicel-PH102) and Magnesium stearate (Ligamed MF-2-V).</p><p><strong>Film coating composition: </strong>Hypromellose 2910, Hydroxyl Propyl Cellulose, Titanium dioxide, Talc and Carnuba Wax<strong>.</strong></p><p>What Peploc looks like?</p><p><strong>&nbsp;</strong></p><p><strong>Peploc 10 mg :</strong></p><p><strong>&nbsp;</strong></p><p>White, round, biconvex, film coated&nbsp; tablets, debossed with &#39;T&#39; on one side and &quot;10&quot; on the other side. Famotidine Tablets USP 20 mg</p><p>Peploc 20 mg :</p><p>Light Yellow, round, biconvex, film coated tablets, debossed with &#39;T&#39; on one side and &quot;11&quot; on the other side</p><p>Peploc40 mg :</p><p>White, round, biconvex, film coated tablets, debossed with &#39;T&#39; on one side and &quot;12&quot; on the other side.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Peploc is Supplied in 10’s Blister pack.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Saudi Amarox Industrial Company</p><p>Aljameah Street, Malaz quarter, Riyadh 11441 Saudi Arabia Tel: +966 11 477 2215</p><p>Manufacture:&nbsp;</p><p>M/s Annora Pharma Private Limited ,India</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                December, 2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي بيبلوك على المادة الفعالة فاموتيدين والتي تنتمي إلى مجموعة من الأدوية تسمى مناهضات مستقبلات H2 تعمل هذه عن طريق تقليل كمية الحمض التي تنتجها معدتك.</p><p dir="RTL">يستخدم فاموتيدين لعلاج ما يلي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرحة المعدة (قرحة المعدة / الاثني عشر)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تهيج خفيف إلى متوسط والتهاب ناتج عن تسرب حمض المعدة إلى المريء (التهاب المريء الارتجاعي)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة زولينجر إليسون (اضطراب نادر يتضمن تقرحات وأورامًا متكررة في المعدة والأمعاء)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong><strong>لا تستخدم بيبلوك أقراص</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك حساسية من فاموتيدين ، أو مضادات مستقبلات H2 الأخرى أو أي من المكونات الأخرى لهذا الدواء (المدرجة في القسم 6).</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل تناول بيبلوك وذلك في الحالات التالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان هناك احتمال وجود ورم خبيث في معدتك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في الكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول جرعة عالية من بيبلوك لفترة طويلة. قد يراقب طبيبك تعداد الدم ووظائف الكبد</p><p dir="RTL"><strong>الأدوية الأخرى وتناول بيبلوك أقراص</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى ، بما في ذلك الأدوية التي تم الحصول عليها بدون وصفة طبية. وهذا يشمل الأدوية العشبية.</p><p dir="RTL">الأدوية التي قد تتفاعل مع بيبلوك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كيتوكونازول (يجب تناوله قبل ساعتين من بيبلوك) أو إيتراكونازول ، الذي يستخدم لعلاج الالتهابات الفطرية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البروبينيسيد ، الذي يستخدم لعلاج النقرس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مضادات الحموضة لعسر الهضم (يجب تناول بيبلوك قبل 1-2 ساعة من تناول مضاد للحموضة)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سكرالفات ، التي تستخدم لعلاج ومنع تكرار القرحة (لا ينبغي أن تتناول سكرالفات في غضون ساعتين من تناول بيبلوك)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كربونات الكالسيوم ، عند استخدامها كدواء لارتفاع مستويات الفوسفات في الدم لدى مرضى غسيل الكلى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أتازانافير المستخدم في علاج عدوى الإيدزHIV</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">إذا كنت حاملاً أو مرضعة ، تعتقدين أنك حامل أو تخططين لإنجاب طفل ، اسألي طبيبك للحصول على المشورة قبل تناول هذا الدواء.</p><p dir="RTL"><strong>الحمل</strong></p><p dir="RTL">إذا كنت حاملاً أو تشك في أنك حامل ، فلا يجب عليك تناول بيبلوك إلا إذا اعتقد طبيبك أن الفوائد تفوق المخاطر.</p><p dir="RTL"><strong>الرضاعة الطبيعية</strong></p><p dir="RTL">إذا كنت مرضعة ، يجب عليك إما التوقف عن تناول بيبلوك أو التوقف عن الرضاعة الطبيعية حيث يتم إفرازه في حليب الثدي.</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">أثناء تناول بيبلوك ، قد تشعر بالدوار أو الصداع. إذا ظهرت عليك هذه الأعراض ، فلا يجب عليك القيادة أو تشغيل الآلات أو القيام بأنشطة تتطلب منك أن تكون متيقظًا ولديك ردود فعل سريعة.</p><p dir="RTL"><strong>&nbsp;</strong><strong>محتوي بيبلوك من اللاكتوز</strong></p><p dir="RTL">يحتوي بيبلوك على اللاكتوز مونوهيدرات. إذا أخبرك طبيبك أن لديك حساسية تجاه بعض السكريات ، فاتصل بطبيبك قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائما تناول بيبلوك تماما كما أخبرك طبيبك. يجب عليك مراجعة طبيبك أو الصيدلي إذا لم تكن متأكدًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب تناول هذه الأقراص عن طريق الفم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خط التقسيم موجود فقط لمساعدتك على كسر القرص إذا كنت تواجه صعوبة في ابتلاعه بالكامل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكن تناول بيبلوك مع أو بدون طعام.</p><p dir="RTL"><strong>البالغين وكبار السن</strong></p><p dir="RTL"><strong>قرحة المعدة</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة الموصى بها هي 40 ملجرام مرة في اليوم ليلاً.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تتراوح مدة العلاج عادة ما بين 4-8 أسابيع. في معظم الحالات ، تلتئم القرحة بهذا العلاج في غضون 4 أسابيع. إذا لم تلتئم القرحة تمامًا ، فقد يستمر العلاج لمدة 4 أسابيع أخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لعلاج القرحة المتكررة الجرعة الموصى بها 20 ملجرام ليلاً.</p><p dir="RTL"><strong>متلازمة زولينجر إليسون</strong></p><p dir="RTL">الجرعة الموصى بها هي 20 ملجرام كل 6 ساعات. يجب بعد ذلك تعديل الجرعة.</p><p dir="RTL"><strong>التهاب المريء الارتجاعي</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة الموصى بها لعلاج الأعراض الخفيفة هي 20 ملجرام مرتين في اليوم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة الموصى بها لعلاج الأعراض الخفيفة إلى المتوسطة هي 40 ملجرام مرتين في اليوم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب أن يستمر العلاج لمدة 6-12 أسبوع.</p><p dir="RTL"><strong>مرضى الكلى / الذين يخضعون لغسيل الكلى</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من اضطرابات في الكلى ، فمن المرجح أن يقوم طبيبك بتقليل جرعتك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب إعطاء بيبلوك في نهاية الغسيل الكلوي أو بعده حيث يتم إزالة بعض المكون الفعال عن طريق غسيل الكلى.</p><p dir="RTL"><strong>الاستخدام في الأطفال</strong></p><p dir="RTL">بيبلوك لا ينصح به للأطفال.</p><p dir="RTL"><strong>تناول جرعة زائدة من بيبلوك أقراص</strong></p><p dir="RTL">إذا تناولت عددًا كبيرًا جدًا من الأقراص عن طريق الخطأ ، فاتصل بطبيبك أو قسم الطوارئ في أقرب مستشفى</p><p dir="RTL">على الفور للحصول على المشورة. تذكر أن تأخذ هذه النشرة أو أي أقراص متبقية معك.</p><p dir="RTL"><strong>إذا نسيت أن تتناول بيبلوك</strong></p><p dir="RTL">يجب أن تتناول الجرعة بمجرد أن تتذكرها ، إلا إذا كان الوقت قد حان لجرعتك التالية. إذا فاتتك جرعة ، فلا تتناول جرعة مضاعفة لتعويض الجرعة المنسية.</p><p dir="RTL"><strong>التوقف عن تناول بيبلوك</strong></p><p dir="RTL">من المهم أن تستمر في تناول بيبلوك طالما أخبرك طبيبك بذلك.</p><p dir="RTL">في حالة مرض القرحة طويل الأمد ، يجب تجنب الانسحاب المفاجئ بعد تخفيف الأعراض. إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء ، اسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية ، يمكن أن يسبب بيبلوك آثارًا جانبية ، على الرغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">اطلب المشورة الطبية فورًا إذا ظهرت عليك الأعراض التالية:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ردود الفعل التحسسية: انتفاخ الوجه أو الحلق أو اللسان ، صعوبة في التنفس أو دوار (الحساسية المفرطة).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التنفس أو أزيز (تشنج قصبي)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ظهور تقرحات شديدة في الجلد والفم والعينين والأعضاء التناسلية (متلازمة ستيفنز جونسون ، انحلال البشرة النخري السمي).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق التنفس أو السعال الجاف بسبب التهاب الرئتين (الالتهاب الرئوي الخلالي).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الطبقات العميقة من الجلد الناجم عن تراكم السوائل (الوذمة الوعائية العصبية).</p><p dir="RTL">أعراض جانبية شائعة (قد تظهر لدى حتى 1 من كل 10 أشخاص).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع الراس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوار</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إمساك</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال</p><p dir="RTL">أعراض جانبية غير شائعة (قد تظهر لدى حتى 1 من كل 100 شخص).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعوربالإعياء (الغثيان / القيء).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجع بطن</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التجشؤ الشديد/ الشعور بالانتفاخ (انتفاخ البطن).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التعب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فم جاف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب التذوق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة شديدة (حكة).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متسرع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي مع تكون البثور (الشرى).</p><p dir="RTL">أعراض جانبية نادرة (قد تظهر لدى حتى 1 من بين 1000 شخص).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في إنزيمات الكبد في الدم (يتم الكشف عنها من خلال اختبارات الدم).</p><p dir="RTL">أعراض جانبية نادرة جدًا (قد تظهر لدى أقل من 1 من بين 10000 شخص).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد الصفائح الدموية ، مما يزيد من خطر حدوث نزيف أو كدمات (قلة الصفيحات الدموية).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في خلايا الدم البيضاء (قلة الكريات البيض ، قلة العدلات).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد خلايا الدم البيضاء مما قد يزيد من احتمالية حدوث العدوى (ندرة المحببات).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض عدد خلايا الدم التي يمكن أن تسبب الضعف أو الكدمات أو تزيد من احتمالية الإصابة بالعدوى (قلة الكريات الشاملة).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاضطرابات النفسية بما في ذلك:</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; الهلوسة (رؤية أو سماع أشياء غير حقيقية).</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; الارتباك.</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات القلق.</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; الأرق (الانفعالات).</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; الاكتئاب.</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات الوظيفة الجنسية (انخفاض الرغبة الجنسية).</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في النوم (الأرق).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم القدرة على الحفاظ على الانتصاب (الضعف الجنسي).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وخز أو تنميل في اليدين أو القدمين (مذل).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النعاس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النوبات (التشنجات) ، نوبات الصرع بما في ذلك نوبات الصرع الكبير (خاصة في المرضى الذين يعانون من مشاكل في الكلى).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر (الثعلبة).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق الصدر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشنجات العضلات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام المفاصل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الكبد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد وبياض العينين (اليرقان).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اختبارات وظائف الكبد غير الطبيعية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاقم أمراض الكبد الموجودة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم انتظام ضربات القلب حيث ينبض القلب ببطء شديد (الإحصار الأذيني البطيني).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب نبضات القلب / عدم انتظام ضربات القلب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالة نظم القلب التي قد تسبب تسارع ضربات القلب (إطالة QT) (خاصة في المرضى الذين يعانون من ضعف وظائف الكلى).</p><p dir="RTL">أعراض جانبية أخرى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تضخم الثدي عند الرجال (تثدي الرجل) (غير معروف إذا كان ناتجًا عن بيبلوك)</p><p><strong>الإبلاغ عن الآثار الجانبية: </strong></p><p dir="RTL">إذا ظهرت لديك أي آثار جانبية ، تحدث إلى طبيبك أو الصيدلي. يتضمن ذلك أي آثار جانبية محتملة غير مذكورة في هذه النشرة. من خلال الإبلاغ عن الآثار الجانبية ، يمكنك المساعدة في توفير مزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ هذا الدواء بعيدًا عن رؤية ومتناول أيدي الأطفال.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة بعد EXP. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا يتطلب هذا المنتج الطبي أي شروط تخزين خاصة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تتخلص من الأدوية في مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ماذا يحتوي بيبلوك أقراص على:</strong></p><p dir="RTL">المادة الفعالة هي فاموتيدين.</p><p dir="RTL"><strong>بيبلوك أقراص </strong><strong>10</strong><strong> ملجرام</strong></p><p dir="RTL">يحتوي كل قرص مغلف على فاموتيدين المتوافق مع دستور الأدوية الأمريكي 10 &nbsp;ملجرام.</p><p dir="RTL">الصواغات الأخرى هي: السليلوز دقيق التبلور (أفيسيل- PH101) ، نشا الذرة (نشا الذرة البيضاء الإضافية) ، نشا الصوديوم جليكولات النوع أ (بريموجيل) ، هيبروميلوز 2910 5cps (ميثوسيل E5-LV Premium) ، السليلوز دقيق التبلور (أفيسيل- PH102) وستيرات الماغنيسيوم (Ligamed MF-2-V ).</p><p dir="RTL">الصواغات الأخرى لطبقة الكسوة الخارجية هي: هيبروميلوز 2910 ، هيدروكسي بروبيل السليلوز ، ثاني أكسيد التيتانيوم ، التلك وشمع كارنوبا.</p><p dir="RTL"><strong>بيبلوك أقراص </strong><strong>20</strong><strong> ملجرام</strong></p><p dir="RTL">يحتوي كل قرص مغلف على فاموتيدين المتوافق مع دستور الأدوية الأمريكي 20 ملجرام.</p><p dir="RTL">الصواغات الأخرى هي: السليلوز دقيق التبلور (أفيسيل- PH101) ، نشا الذرة (شرائط الذرة البيضاء الإضافية) ، نشا الصوديوم جلايكولات النوع أ (بريموجيل) ، هيبروميلوز 2910 5 cps (ميسوثيل E5-LV Premium) ، السليلوز دقيق التبلور (أفيسيل- PH102) و ستيرات الماغنيسيوم (Ligamed MF-2-V).</p><p dir="RTL">تركيبة طلاء الفيلم: هيبروميلوز 2910 ، هيدروكسيل بروبيل سليلوز ، ثاني أكسيد التيتانيوم ، تلك ، شمع كارنوبا ، أكسيد الحديد الأصفر وأكسيد الحديد الأحمر.</p><p dir="RTL"><strong>بيبلوك أقراص </strong><strong>40</strong><strong> ملجرام</strong></p><p dir="RTL">يحتوي كل قرص مغلف على فاموتيدين المتوافق مع دستور الأدوية الأمريكي &nbsp;</p><p dir="RTL">40 ملجرام.</p><p dir="RTL">الصواغات الأخرى هي: السليلوز دقيق التبلور (أفيسيل- PH101) ، نشا الذرة (شرائط الذرة البيضاء الإضافية) ، نشا الصوديوم جلايكولات النوع أ (بريموجيل) ، هيبروميلوز 2910 5 cps (ميسوثيل E5-LV Premium) ، السليلوز دقيق التبلور (أفيسيل- PH102) و ستيرات الماغنيسيوم (Ligamed MF-2-V).</p><p dir="RTL">الصواغات الأخرى لطبقة الكسوة الخارجية هي: هيبروميلوز 2910 ، هيدروكسيل بروبيل سليلوز ، ثاني أكسيد التيتانيوم ، تالك وشمع كارنوبا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>بيبلوك أقراص </strong><strong>10</strong><strong> ملجرام</strong></p><p dir="RTL">أقراص بيضاء ، مستديرة ، محدبة من الجانبين ، مغلفة بطبقة رقيقة ، منقوش عليها حرف &quot;T&quot; على جانب واحد و &quot;10&quot; على الجانب الآخر.</p><p dir="RTL"><strong>بيبلوك أقراص </strong><strong>20</strong><strong> ملجرام</strong></p><p dir="RTL">أقراص صفراء فاتحة ، مستديرة ، محدبة من الجانبين ، مغلفة بطبقة رقيقة ، منقوش عليها حرف &quot;T&quot; على جانب واحد و &quot;11&quot; على الجانب الآخر</p><p dir="RTL"><strong>بيبلوك أقراص </strong><strong>40</strong><strong> ملجرام</strong></p><p dir="RTL">أقراص بيضاء ، مستديرة ، محدبة من الجانبين ، مغلفة بطبقة رقيقة ، منقوش عليها حرف &quot;T&quot; على جانب واحد و &quot;12&quot; على الجانب الآخر.</p><p dir="RTL"><strong>كيفية توفير بيبلوك أقراص؟</strong></p><p dir="RTL">يتم توفير أقراص بيبلوك في شرائط تحتوي على (3&times;10) أقراص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شركة اماروكس السعودية الصناعية</strong></p><p>شارع الجامعة &ndash; الملز &ndash; الرياض 12629</p><p>المملكة العربية السعودية.</p><p dir="RTL">تليفون: +966112268850</p><p dir="RTL"><strong>المصنع:</strong> شركة أنورا فارما، الهند</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة في نوفمبر 2022 ، نسخة 
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Peploc (Famotidine Tablets USP 10 mg, 20 mg and 40 mg)
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Peploc (Famotidine Tablets USP 10 mg)
Each tablet contains 10mg of Famotidine USP.
Peploc (Famotidine Tablets USP 20 mg)
Each tablet contains 20mg of Famotidine USP.
Peploc (Famotidine Tablets USP 40 mg)
Each tablet contains 40mg of Famotidine USP.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Peploc (Famotidine Tablets USP 10 mg)
White, round, biconvex, film coated tablets, debossed with 'T' on one side and "10" on the other side.
Peploc (Famotidine Tablets USP 20 mg)
Light Yellow, round, biconvex, film coated tablets, debossed with 'T' on one side and "11" on the other side
Peploc (Famotidine Tablets USP 40 mg)
White, round, biconvex, film coated tablets, debossed with 'T' on one side and "12" on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Duodenal ulcers and prevention of relapses of duodenal ulceration.<br />Benign gastric ulcers.<br />Zollinger-Ellison syndrome</p><p>Symptomatic treatment of mild to moderate reflux oesophagitis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Adults<br />Duodenal ulcers - The initial recommended dose is 40 mg of famotidine to be taken at night. Healing generally occursin most patients within 4 weeks. This period, however, may be shortened if an endoscopic examination reveals that theulcer has healed. However, in those patients whose ulcers have not healed within this 4 week period, treatment shouldcontinue for a further 4 weeks.<br />Prevention of relapses of duodenal ulceration - To prevent ulcers from reoccurring the recommended dose is 20 mg offamotidine to be taken at night.<br />Benign gastric ulcers - The recommended dose of 40 mg of famotidine to be taken at night. Treatment should continuefor between 4-8 weeks unless earlier healing is revealed by endoscopy.<br />Zollinger-Ellison syndrome - Patients who are not receiving any antisecretory therapy should be started on a dose of 20mg of famotidine every 6 hours. The dosage should then be adjusted to individual response. Doses up to 800 mg dailyhave been used up to one year without the development of significant adverse effects or tachyphylaxis.<br />If the desired inhibition of acid secretion cannot be attained with a daily dosage of 800 mg, alternative treatment shouldbe considered to regulate acid secretion, since no long term experience with dosages of more than 800 mg offamotidine/day have been recorded.<br />Treatment should be continued for as long as necessary. Patients who have been receiving other H-receptorantagonist treatment may be switched directly to famotidine treatment at a higher dosage than the initial dosage that isusually recommended. The starting dosage will depend on the severity of the condition and the size of the last dose ofH-antagonist previously used.<br />Symptomatic treatment of mild to moderate oesophagitis - The recommended dose in case of mild oesophagitis is 20mg of famotidine twice daily. In case of mild to moderate oesophagitis, the recommended dose is 40 mg twice daily.Generally treatment should be conducted for 6 weeks. If the condition has not improved, treatment should be continuedfor a further 6 weeks.<br />Renal impairment:</p><p>Famotidine is primarily eliminated via the kidneys. For patients with impaired renal function in whom creatinineclearance is less than 30 ml/min, the daily dose of famotidine should be reduced by 50%. Caution is advised inpatients with renal impairment.<br />Dialysis patients should also take dosages that are reduced by 50%. Famotidine 20 mg tablets should be administeredat the end of dialysis or thereafter since some of the active ingredient is removed by dialysis.<br />Elderly:<br />The dosage regimen recommended for elderly patients is the same as for adults.<br />Paediatric population:<br />The efficacy and safety of famotidine in children have not been established.<br />Method of administration<br />For oral use.<br />Famotidine tablets can be taken with or without food (see section 5.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Cross sensitivity in this class of compounds has been observed. Therefore, Famotidine should not be administered topatients with a history of hypersensitivity to other H-receptor antagonists.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Gastric neoplasm<br />The presence of gastric malignanncy should be excluded prior to the use of famotidine for the treatment of gastriculcers. Symptomatic responses of gastric ulcers following treatment with famotidine do not preclude the presence ofgastric malignancy.<br />Renal insufficiency<br />As famotidine is excreted primarily via the kidneys, caution should be exercised when treating patients who aresuffering from impaired renal function. A reduction in the daily dose to 20 mg at night should be considered if creatinineclearance falls below 10 ml/min (see section 4.2).<br />Paediatric population<br />The safety and efficacy for the use of Famotidine in children has not been established.<br />Use in the elderly</p><p>When famotidine was administered to elderly patients in clinical trials, no increase in the incidence or change in the type of drug-related side effects was observed. No dosage adjustment is required based on age alone.<br />General<br />In case of long-term treatment with high dosage, monitoring of blood count and liver function is recommended.<br />In case of long-standing ulcer disease, abrupt withdrawal after symptom relief should be avoided.<br />This medicine contains lactose.<br />This medicinal product contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose galactose malabsorption should not take this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinically important drug interactions have been identified.<br />Famotidine does not interact with the cytochrome P450 drug metabolising enzyme system. Compounds metabolised by this system, which have been tested in man have included warfarin, theophylline, phenytoin, diazepam, propranolol,aminopyrine and antipyrine.<br />Indocyanide green as an index of hepatic blood flow and/or hepatic drug extraction has been tested and no significanteffects have been found.<br />Studies in patients stabilised on phenprocoumon therapy have shown no pharmacokinetic interaction with famotidineand no effect on the pharmacokinetic or anticoagulant activity of phenprocoumon.<br />In addition, studies with famotidine have shown no augmentation of expected blood alcohol levels resulting from alcoholingestion.<br />lterations of gastric pH may affect the bioavailability of certain drugs, resulting in a decrease in the absorption ofatazanavir. The absorption of ketoconazole and itraconazole could be reduced. Ketoconazole should be administeredtwo hours before famotidine.<br />Probenecid inhibits the renal tubular secretion of famotidine and has been shown to cause a 50% increase infamotidine plasma concentrations. Therefore, concomitant use of probenecid and famotidine should be avoided.</p><p>Concomitant use of famotidine and antacids could reduce the famotidine absorption and lead to lower plasma levels offamotidine. Therefore, famotidine should be administered 1-2 hours before taking an antacid.<br />Concomitant use of sucralfate inhibits the absorption of famotidine. Therefore, sucralfate should not be administeredwithin 2 hours of the famotidine dose.<br />Risk of loss of efficacy of calcium carbonate when co-administered as phosphate binder with famotidine inhaemodialysis patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy:<br />Famotidine is not recommended for use in pregnancy, and should be prescribed only if clearly needed. Before adecision is made to use famotidine during pregnancy, the physician should weigh the potential benefits from the drugagainst the possible risks involved.<br />Breast-feeding:<br />Famotidine is excreted in human breast milk. Therefore breast-feeding mothers should either stop taking famotidine orstop breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Some patients have experienced adverse reactions such as dizziness and headache while taking famotidine. Patientsshould be informed that they should avoid driving vehicles or operating machinery or doing activities which requireprompt vigilance if they experience these symptoms (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Famotidine has been demonstrated to be generally well-tolerated.<br />Adverse reactions are ranked under the heading of frequency, the most frequent first, using the following convention:Very Common (&gt;1/10), Common (&gt;1/100, &lt;1/10), Uncommon (&gt;1/1000, &lt;1/100), Rare (&gt;1/10,000, &lt;1/1,000), VeryRare (&lt;1/10,000), including isolated cases not known (cannot be estimated from the available data).<br />Blood and lymphatic system disorders<br />Very rare<br />Thrombocytopenia<br />Leukopenia</p><p>Agranulocytosis<br />Pancytopenia<br />neutropenia<br />Immune system disorders<br />Very rare<br />Hypersensitivity reactions (angioneurotic oedema, anaphylaxis, bronchospasm)<br />Metabolism and nutrition disorders<br />Uncommon<br />Loss of appetite (anorexia)<br />Psychiatric disorders<br />Very rare<br />Reversible psychological disturbances including:<br />Hallucinations<br />Disorientation<br />Confusion<br />Anxiety disorders<br />Agitation<br />Depression<br />Reduced libido<br />Insomnia.<br />Nervous system disorders<br />Common<br />Headache<br />Dizziness<br />Uncommon<br />Taste disorder<br />Very rare<br />Paraesthesia<br />Somnolence<br />Convulsions</p><p>Grand mal seizures (particularly in patients with impaired renal function)<br />Cardiac disorders<br />Very rare<br />AV block with H-receptor antagonists administered intravenously<br />Arrhythmias<br />QT prolongation (especially in patients with impaired renal function)<br />Respiratory, thoracic and mediastinal disorders<br />Very rare<br />Interstitial pneumonia, sometimes fatal<br />Gastrointestinal disorders<br />Common<br />Constipation<br />Diarrhoea<br />Uncommon<br />Nausea and or vomiting<br />Abdominal discomfort or distension<br />Flatulence<br />Dry mouth<br />Hepato-biliary disorders<br />Very rare<br />Hepatitis<br />Cholestatic jaundice<br />Liver enzyme abnormalities<br />Isolated cases of worsening of existing hepatic disease<br />Skin and subcutaneous tissue disorders<br />Uncommon<br />Rash<br />Pruritus<br />Urticaria<br />Very rare</p><p>Stevens Johnson syndrome/toxic epidermal necrolysis sometimes fatal<br />Muscoskeletal and connective tissue disorders<br />Very rare<br />Muscle cramps<br />Arthralgia<br />Reproductive system and breast disorders<br />Very rare<br />Impotence<br />General disorders and administration site conditions<br />Uncommon: fatigue<br />Very rare: chest tightness<br />Investigations<br />Rare<br />Increase in laboratory values (transaminases, gamma GT, alkaline phosphatase, bilirubin).<br />Adverse Effects - Causal Relationship Unknown<br />Rare cases of gynecomastia, have been reported, however, in controlled clinical trials the incidences were not greaterthan those seen with placebo.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The adverse reactions in overdose cases are similar to the adverse reactions encountered in normal clinical experience(see section 4.8).<br />In the event of overdose the usual measures to remove unabsorbed material from the gastrointestinal tract, clinicalmonitoring and supportive therapy should be employed.<br />Patients suffering from Zollinger-Ellison syndrome have tolerated doses of up to 800 mg/day. These patients have beentreated for more than a year without the development of any significant adverse effects.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC code: A02B A03<br />Pharmacotherapeutic group: Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD), H2 -receptorantagonists.<br />Clinical efficacy and safety<br />In healthy volunteers, single oral doses of famotidine (5 mg to 40 mg) produced dose related inhibition of basal andpentagastrin, betazole or insulin-stimulated gastric secretion. In addition, pepsin levels were also reduced and therewas a decrease in the volume of the basal gastric juice and the gastric juice secreted on stimulation. Similar inhibitory effects on gastric secretion were also noted in patients with benign gastric or duodenal ulceration</p><p>In contrast to control subjects on cimetidine 300 mg or on placebo, inhibition of gastric secretion persisted involunteers given a second pentagastrin challenge 5-7 hours after the initial dose of famotidine.<br />A single oral dose of 40 mg of famotidine, given at 9 pm was effective for more than 12 hours after administration andhad some continuing effect through the breakfast meal. The duration of action of the 80 mg dose of famotidineadministered at 9 pm was no longer than the 40 mg dose.<br />In several studies, 10 mg and 20 mg doses of famotidine increased basal serum gastrin levels, however the levelsremained unchanged in others. Gastric emptying, and hepatic and portal blood flows were unaltered by famotidine. Inaddition, famotidine did not cause changes in endocrine function.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption.<br />Famotidine is rapidly absorbed and takes effect within an hour of oral administration, reaching dose-related peakplasma concentration within 1-3 hours. Oral bioavailability is not affected by the presence of food in the stomach.Repeat doses do not lead to accumulation of the drug.<br />Distribution.<br />There is relatively low (15-20%) protein binding of famotidine in the plasma. The plasma half-life after a single oral doseand or multiple repeated doses (for 5 days) was approximately 3 hours.<br />Biotransformation<br />Famotidine is metabolised in the liver, with formation of the inactive sulfoxide metabolite.<br />Elimination<br />Famotidine is excreted mainly unchanged in the urine (25-60%); a small amount of the drug may be excreted assulfoxide.<br />Linearity/non-linearity<br />Famotidine displays linear kinetics</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no pre-clinical data of relevance to the prescriber which are additional to that already included in othersections of the SPC.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Peploc (Famotidine Tablets USP 10mg):<br />Microcrystalline Cellulose (Avicel-PH101), Corn Starch (Extra white maize Strach), Sodium Starch Glycolate Type A (Primojel), Hypromellose 2910 5cps (Methocel E5-LV Premium), Microcrystalline Cellulose (Avicel-PH102) and Magnesium stearate (Ligamed MF-2-V).<br />Film coating composition: Hypromellose 2910, Hydroxyl Propyl Cellulose, Titanium dioxide, Talc and Carnuba Wax.<br />Peploc (Famotidine Tablets USP 20mg):<br />Microcrystalline Cellulose (Avicel-PH101), Corn Starch (Extra white maize Strach), Sodium Starch Glycolate Type A (Primojel), Hypromellose 2910 5cps (Methocel E5-LV Premium), Microcrystalline Cellulose (Avicel-PH102) and Magnesium stearate (Ligamed MF-2-V).<br />Film coating composition: Hypromellose 2910, Hydroxyl Propyl Cellulose, Titanium dioxide, Talc, Carnuba Wax, Yellow Iron Oxide and Red Iron Oxide.<br />Peploc (Famotidine Tablets USP 40mg):<br />Microcrystalline Cellulose (Avicel-PH101), Corn Starch (Extra white maize Strach), Sodium Starch Glycolate Type A (Primojel), Hypromellose 2910 5cps (Methocel E5-LV Premium), Microcrystalline Cellulose (Avicel-PH102) and Magnesium stearate (Ligamed MF-2-V).<br />Film coating composition: Hypromellose 2910, Hydroxyl Propyl Cellulose, Titanium dioxide, Talc and Carnuba Wax.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&ordm;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>10&rsquo;s Blister pack</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Saudi Amarox Industrial Company
Aljameah Street, Malaz quarter, Riyadh 11441
Saudi Arabia
Tel: +966 11 477 2215
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                December-2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>